Unclaimed brand
THE CLAUDIN-1 COMPANY Treat cancer and reverse fibrosis We are a clinical-stage biotech company with a mission to treat cancer and reverse fibrosis. To this end, we are rapidly advancing our pipeline of anti-Claudin-1 antibody-drug conjugates (ADCs) and monoclonal antibodies. Our team is committed to unlocking the broad potential of our therapeutic target Claudin-1 and […]
Liking this brand profile? Share this page


Hex Code
Color name
RGB
HSL
CMYK
#0090A9
Bondi Blue
0, 144, 169
189, 100, 33
100, 15, 0, 34
#8ED1FC
Malibu
142, 209, 252
203, 95, 77
44, 17, 0, 1
#A9B8C3
Cadet Blue
169, 184, 195
205, 18, 71
13, 6, 0, 24
Alentis Therapeutics is a clinical-stage biotechnology company based in Allschwil, Switzerland, focused on developing treatments for cancer and fibrosis. The company’s research centers on Claudin-1, a therapeutic target that its antibodies are designed to address. Alentis says its anti-Claudin-1 therapies can help open stiff extracellular matrix tissue and block disease signaling; in cancer, they are also designed to selectively kill tumor cells.
Its pipeline includes antibody-drug conjugates (ADCs) and monoclonal antibodies at clinical and preclinical stages. Clinical candidates include ALE.P02, an ADC being developed for squamous cancers, and lixudebart (ALE.F02), a monoclonal antibody for organ fibrosis. The company is also developing ALE.P03 and other preclinical anti-Claudin-1 approaches. Through these programs, Alentis aims to advance new treatment options for patients affected by cancer and fibrotic disease. Its work is supported by a leadership team, Board of Directors, and Scientific Advisory Board, and the company shares research updates, publications, and news about its programs and partnerships.
Company type
Privately Held
Year founded
2019
Company size
11-50 employees
Anti-Claudin-1 antibody therapeutics
Claudin-1 antibody-drug conjugates
Organ fibrosis drug development
Claudin-1-positive solid tumor therapies
How do I download the Alentis Therapeutics logo?
The Alentis Therapeutics logo comes in two versions: a logo and an icon. Download as transparent PNG or JPEG.
What does Alentis Therapeutics' branding look like?
The Alentis wordmark pairs a distinctive, angular A formed from fine intersecting strokes with a light “Alentis” name and widely spaced “THERAPEUTICS” lettering. Its visual system uses clean, widely tracked sans lettering, teal and blue-green fields with white typography, bright lime accents, and restrained scientific imagery and spacious layouts.
What are Alentis Therapeutics' brand colors?
The Alentis Therapeutics color palette uses the hex codes #0090A9, #8ED1FC and #A9B8C3.
The Alentis Therapeutics name, logos and brand assets are trademarks of Alentis Therapeutics and its affiliates. Brandfetch isn't affiliated with or endorsed by Alentis Therapeutics. Their use is subject to Alentis Therapeutics's brand guidelines.